China Mice Model Market (2025-2030)
The China Mice Model Market was valued at $107.6 Million in 2025 and projected to reach to $183.7 Million by 2030, representing a compound annual growth rate of 11.3%. China's mice model market is positioned for substantial growth through 2030, supported by the nation's strategic focus on becoming a global biomedical research hub.
China Mice Model Market Trends and Insights
- This 11.3% compound annual growth rate reflects China's accelerating investment in biomedical research and pharmaceutical development.
- China's expanding research infrastructure, coupled with government support for life sciences innovation, is driving increased demand for laboratory mice across academic institutions, contract research organizations, and pharmaceutical companies. The mice model market in China is benefiting from the country's rising focus on precision medicine and drug discovery.
- China's biotechnology sector has matured significantly, with numerous domestic and international pharmaceutical firms establishing research centers that require reliable mouse models for preclinical testing.
- Between 2025 and 2030, China is expected to solidify its position as a critical hub for translational research, further boosting the adoption of standardized and genetically modified mouse models throughout the healthcare and life sciences ecosystem..
Key Market Statistics
- CAGR (2025-2030) 11.3% CAGR
- Market Size, 2025 ~USD 107.6 Million
- Forecast, 2030 ~USD 183.7 Million
- Country China
China Mice Model Market Overview
Rapid Market Expansion :
China's mice model market is growing at 11.3% CAGR, outpacing the global average of 10%, driven by increased R&D spending and pharmaceutical innovation initiatives across the country.
Government-Backed Research Infrastructure :
Chinese government investments in life sciences and biomedical research are creating favorable conditions for mice model adoption, with expanded laboratory facilities and funding for preclinical studies.
Pharmaceutical Development Acceleration :
China's booming pharmaceutical sector is increasingly relying on mice models for drug discovery and safety testing, supporting market growth from 107.6 million USD in 2025 to 183.7 million USD by 2030.
Academic and Commercial Research Growth :
Universities and biotech companies in China are scaling up preclinical research programs, creating sustained demand for genetically modified and specialized mice models for disease research.
China Mice Model Market Dynamics
- Government initiatives promoting life sciences innovation, combined with increased pharmaceutical R&D budgets, are accelerating adoption of advanced mouse models in preclinical research.
- The market benefits from China's expanding contract research organization (CRO) sector and growing collaborations between domestic and international pharmaceutical companies. The forecast period will see intensified demand from academic institutions, biotech startups, and multinational pharmaceutical firms establishing research centers in China.
- Investment in specialized breeding facilities and genetically engineered mouse models will drive market diversification.
- Regulatory harmonization with international standards and rising awareness of animal model importance in drug development will further propel market expansion through 2030..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- China's mice model market is valued at USD 107.6 million in 2025 and is forecast to reach USD 183.7 million by 2030, representing a 11.3% CAGR.
- China's government support for biomedical research and precision medicine initiatives is a primary driver of market expansion.
- China's growing pharmaceutical and biotechnology sectors are increasing demand for standardized and genetically modified mouse models.
- China is emerging as a critical hub for translational research, positioning the country for sustained market growth through 2030.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
China Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : Chinese and multinational pharma firms need market insights to optimize preclinical research budgets, select appropriate mouse model suppliers, and accelerate drug development timelines in China's competitive landscape.
- Biotech & CRO Executives : Biotech startups and contract research organizations require detailed market data to identify growth opportunities, benchmark against competitors, and strategically position services for China's expanding research sector.
- Research Institution Leaders : University and government research institute directors need market analysis to justify funding requests, plan facility investments, and align preclinical research programs with national biomedical innovation priorities.
- Mice Model Suppliers & Breeders : Domestic and international suppliers require China-specific market intelligence to assess demand trends, identify customer segments, and develop targeted distribution and product strategies for this growing market.
- Investment & Strategy Consultants : Investors and management consultants advising life sciences companies need comprehensive China market data to evaluate investment opportunities, assess market entry feasibility, and guide strategic expansion decisions.
Key Companies in the China Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for China's mice model market (107.6M USD in 2025) with 11.3% CAGR projections through 2030, enabling accurate investment and expansion planning in this high-growth segment.
- Competitive Landscape Intelligence : Understand China-specific market dynamics, key players, and competitive positioning to identify partnership opportunities and market entry strategies tailored to the Chinese biomedical research ecosystem.
- Government Policy & Regulatory Insights : Access analysis of Chinese government initiatives, R&D funding mechanisms, and regulatory frameworks driving mice model adoption, critical for compliance and strategic alignment with local market conditions.
- End-User Demand Segmentation : Identify specific demand drivers across Chinese pharmaceutical companies, academic institutions, and CROs to tailor product offerings and marketing strategies for maximum market penetration.
- Investment & Growth Opportunity Assessment : Leverage comprehensive market forecasts and trend analysis to evaluate ROI potential, identify emerging niches, and make data-driven decisions for R&D investments and facility expansion in China.
Frequently asked questions
What is the current size of China's mice model market?
China's mice model market is valued at USD 107.6 million in 2025 and is expected to grow to USD 183.7 million by 2030.
What is the projected growth rate for China's mice model market?
China's mice model market is projected to grow at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030.
What factors are driving growth in China's mice model market?
Growth in China's mice model market is driven by increased government investment in biomedical research, expansion of pharmaceutical and biotechnology sectors, and rising adoption of precision medicine approaches.
Who are the primary end-users of mice models in China?
Primary end-users in China include academic research institutions, contract research organizations (CROs), pharmaceutical companies, and biotechnology firms engaged in drug discovery and preclinical testing.
How does China's mice model market compare to the global market?
China's mice model market is growing faster than the global average, with a 11.3% CAGR compared to the global CAGR of 10%, reflecting China's accelerating investment in life sciences research.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report